ULURU Inc.
4452 Beltway Drive
Addison,
TX 75001
United States - Map
Phone: 214-905-5145
Fax: 214-905-5130
Web Site: http://www.uluruinc.com
| Uluru Inc., a pharmaceutical company, engages in the research, development, and commercialization of wound management and oral care products worldwide. The companys products are based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial thickness burns, donor sites, and abrasions, as well as surgical, acute, and chronic wounds; Aphthasol and Aptheal for the treatment of canker sores; Residerm A gel-Zindaclin for the treatment of acne; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; and OraDisc B for the treatment and management of oral pain. Uluru is based in Addison, Texas. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Renaat Van den Hooff , 50
Chief Exec. Officer and Pres |
$
407.00K |
$
0 | Mr. Terrance K. Wallberg , 55
Chief Financial Officer, Principal Accounting Officer, VP, Sec. and Treasurer |
$
197.00K |
$
0 | Mr. Daniel G. Moro , 62
VP of Polymer Drug Delivery |
$
174.00K |
$
64.00K | Dr. John V. St. John Ph.D., 38
VP R&D |
$
138.00K |
$
0 | Mr. Christopher J. Stergion ,
Director of Sales and Marketing |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.14% Nasdaq 0.00%
Profile
